Molecular Templates Inc MTEM.O :
* MOLECULAR TEMPLATES: APPROVED LIQUIDATION & WIND UP
THROUGH A
DISSOLUTION
* MOLECULAR TEMPLATES: CONTINUING TO PURSUE STRATEGIC
ALTERNATIVES
AND POTENTIAL FUNDING SOURCES
* MOLECULAR TEMPLATES: INTENDS TO CALL SPECIAL MEETING OF
STOCKHOLDERS TO SEEK APPROVAL OF PLAN OF DISTRIBUTION
* MOLECULAR TEMPLATES: PLANS TO WIND DOWN PHASE 1 CLINICAL
STUDIES
FOR MT-6402 AND MT-8421
* MOLECULAR TEMPLATES: TO CONTINUE DISCUSSIONS WITH FDA WITH
RESPECT TO MT-0169 FOR AUTOIMMUNE INDICATIONS
* MOLECULAR TEMPLATES INC: APPROVED A REDUCTION IN FORCE OF
SUBSTANTIALLY ALL OF COMPANY'S EMPLOYEES
Source text for Eikon: ID:n0001193125-24-236770
Further company coverage: MTEM.O